What’s New in Diabetic Eye Disease Technologies

03/31/23 • 35 min

Half of people with severe non-proliferative diabetic retinopathy will have proliferative disease within a year. What can be done? Credit available for this activity expires: 03/31/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/989799?ecd=bdc_podcast_libsyn_mscpedu

Previous Episode

Biosimilars in Multiple Sclerosis: Entering a New Era of Biologic Therapy

Did you know what the inherent variability of all biologics and what degree of variation are acceptable by regulatory bodies?

Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/989395?src=mkm_podcast_addon_989395

Next Episode

Well Begun Is Half Done: Why and How Do We Assess Activity of the Complement Pathway in the Clinic?

Do you want to gain expert insights on the role of kidney biopsy and complement assays for complement-mediated kidney diseases? Credit available for this activity expires: 4/13/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990635?ecd=bdc_podcast_libsyn_mscpedu